<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">28672946</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1792-0981</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Experimental and therapeutic medicine</Title><ISOAbbreviation>Exp Ther Med</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 infection impairs the reproductive capacity of female mice.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>409</EndPage><MedlinePgn>403-409</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2017.4499</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a major cause of hand, foot and mouth disease (HFMD); however, no clinically approved vaccine or antiviral treatment is currently available for EV71 infection. In the present study, a murine model of EV71 infection was constructed. The clinical isolates of EV71 were amplified in Vero cells and used to challenge adult mice via hydrodynamic injection (HI) and intraperitoneal injection (IP). Following two challenges, &gt;50% of the mice succumbed to EV71 infection. Surviving female mice were identified to have impaired fertility and their litter sizes were significantly decreased compared with the control group. The antibody against EV71-VP1 persisted in the sera of female mice at a high titer for &gt;2 years after challenge. The maternal antibody in the offspring sera also persisted for ~1 year and disappeared after ~2 years. Results from the present study suggest that a high titer of active EV71 was able to impair the reproductivity of adult female mice, and that high levels of maternal antibody persisted in the offspring and protected postnatal mice from EV71-induced mortality. The promising antigenicity, immunogenicity and reactogenicity of EV71 suggests that it a potential vaccine target that may be beneficial to the control of HFMD, through immunizing infants and women of reproductive age.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shaoxing Centre for Disease Control and Prevention, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Qiuyue</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Xiuping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jinkun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shaoxing Centre for Disease Control and Prevention, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xuejun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Exp Ther Med</MedlineTA><NlmUniqueID>101531947</NlmUniqueID><ISSNLinking>1792-0981</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">hydrodynamic injection</Keyword><Keyword MajorTopicYN="N">immunogenicity</Keyword><Keyword MajorTopicYN="N">immunological stress</Keyword><Keyword MajorTopicYN="N">maternal antibody</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>5</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28672946</ArticleId><ArticleId IdType="pmc">PMC5488539</ArticleId><ArticleId IdType="doi">10.3892/etm.2017.4499</ArticleId><ArticleId IdType="pii">ETM-0-0-4499</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ye X, Fan C, Ku Z, Zuo T, Kong L, Zhang C, Shi J, Liu Q, Chen T, Zhang Y, et al. Structural basis for recognition of human enterovirus 71 by a bivalent broadly neutralizing monoclonal antibody. PLoS Pathog. 2016;12:e1005454. doi: 10.1371/journal.ppat.1005454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005454</ArticleId><ArticleId IdType="pmc">PMC4777393</ArticleId><ArticleId IdType="pubmed">26938634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui J, Liu Z, Zhang T, Hua Q, Jiang Z, Chen B, Gu H, Lv H, Dong C. Epidemiological characteristics and spatial-temporal clusters of hand, foot and mouth disease in zhejiang province, China, 2008&#x2013;2012. PLoS One. 2015;10:e0139109. doi: 10.1371/journal.pone.0139109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0139109</ArticleId><ArticleId IdType="pmc">PMC4589370</ArticleId><ArticleId IdType="pubmed">26422015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, Cheng RB, Xiong XY. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J. 2012;9:8. doi: 10.1186/1743-422X-9-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-8</ArticleId><ArticleId IdType="pmc">PMC3268717</ArticleId><ArticleId IdType="pubmed">22230340</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin B, Zhang J, Xie W, Liu X, He T, Chen J, Dong X. Development of a specific latex agglutination test to detect antibodies of enterovirus 71. Arch Med Res. 2015;46:580&#x2013;587. doi: 10.1016/j.arcmed.2015.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2015.09.001</ArticleId><ArticleId IdType="pubmed">26363276</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, Su D, Ni C, Li J, Rao Z, et al. Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog. 2014;10:e1004422. doi: 10.1371/journal.ppat.1004422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004422</ArticleId><ArticleId IdType="pmc">PMC4183573</ArticleId><ArticleId IdType="pubmed">25275585</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Chow YH, Chong P, Klein M. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine. 2014;32:6177&#x2013;6182. doi: 10.1016/j.vaccine.2014.08.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.08.064</ArticleId><ArticleId IdType="pubmed">25218294</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, Yao X, Gao F, Wu X, Xu M, Wang JZ. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother. 2013;9:1701&#x2013;1705. doi: 10.4161/hv.24949.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.24949</ArticleId><ArticleId IdType="pmc">PMC3906269</ArticleId><ArticleId IdType="pubmed">23744508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, Wang X, Zhu L, Hu Z, Gao Q, Yang P, Li X, Wang J, Shen X, Fry EE, et al. Structures of Coxsackievirus A16 capsids with native antigenicity: Implications for particle expansion, receptor binding and immunogenicity. J Virology. 2015;89:10500&#x2013;10511. doi: 10.1128/JVI.01102-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01102-15</ArticleId><ArticleId IdType="pmc">PMC4580203</ArticleId><ArticleId IdType="pubmed">26269176</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang J, Li J, Wei W, Liu X, Liu G, Yang J, Zhang W, Yu XF. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model. Immunol Res. 2015;62:306&#x2013;315. doi: 10.1007/s12026-015-8661-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-015-8661-1</ArticleId><ArticleId IdType="pubmed">26025091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q, He F, Kwang J. Recent Progress towards Novel EV71 anti-therapeutics and vaccines. Viruses. 2015;7:6441&#x2013;6457. doi: 10.3390/v7122949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122949</ArticleId><ArticleId IdType="pmc">PMC4690872</ArticleId><ArticleId IdType="pubmed">26670245</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Fan P, Jin J, Su W, An D, Xu L, Sun S, Zhang Y, Meng X, Gao F, et al. Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J. 2013;10:250. doi: 10.1186/1743-422X-10-250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-250</ArticleId><ArticleId IdType="pmc">PMC3765843</ArticleId><ArticleId IdType="pubmed">23919614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916&#x2013;7924. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih SR, Li YS, Chiou CC, Suen PC, Lin TY, Chang LY, Huang YC, Tsao KC, Ning HC, Wu TZ, Chan EC. Expression of capsid [correction of caspid] protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. J Med Virol. 2000;61:228&#x2013;234. doi: 10.1002/(SICI)1096-9071(200006)61:2&lt;228::AID-JMV9&gt;3.0.CO;2-R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(200006)61:2&lt;228::AID-JMV9&gt;3.0.CO;2-R</ArticleId><ArticleId IdType="pubmed">10797379</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo HT. tCJkZJhJZjHXnFLjQ: A study on genetic characteristics of Enterovirus 71 of hand-foot-mouth disease in Shaoxing city Zhejiang. Prev Med. 2014;26:4.</Citation></Reference><Reference><Citation>Li XD, Li XF, Ye HQ, Deng CL, Ye Q, Shan C, Shang BD, Xu LL, Li SH, Cao SB, et al. Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A. J Gen Virol. 2014;95:806&#x2013;815. doi: 10.1099/vir.0.061838-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.061838-0</ArticleId><ArticleId IdType="pubmed">24362961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, Pan Y, Du J, Guo M, Cao H, et al. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res. 2014;24:1050&#x2013;1066. doi: 10.1038/cr.2014.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2014.116</ArticleId><ArticleId IdType="pmc">PMC4152738</ArticleId><ArticleId IdType="pubmed">25155355</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY, Zhang B. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Antiviral Res. 2013;97:198&#x2013;205. doi: 10.1016/j.antiviral.2012.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.010</ArticleId><ArticleId IdType="pubmed">23267829</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin B, Tu C, Zhang B, He T, Fu L, Xu W. A modified murine model based on hydrodynamic injection for the analysis of chronic human hepatitis B virus infection. Mol Med Rep. 2013;8:1677&#x2013;1682.</Citation><ArticleIdList><ArticleId IdType="pubmed">24141768</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin B, Budeus B, Cao L, Wu C, Wang Y, Zhang X, Rayner S, Hoffmann D, Lu M, Chen X. The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir. Antiviral Res. 2013;97:93&#x2013;100. doi: 10.1016/j.antiviral.2012.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2012.12.007</ArticleId><ArticleId IdType="pubmed">23261845</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen IC, Wang SM, Yu CK, Liu CC. Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice. Med Microbiol Immunol. 2013;202:259&#x2013;265. doi: 10.1007/s00430-013-0289-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-013-0289-y</ArticleId><ArticleId IdType="pubmed">23408291</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Yue YY, Song NN, Li ZH, Meng H. Study on BALB/c mice with EV71 infection by diverse inoculation routes. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2013;27:14&#x2013;17. (In Chinese)</Citation><ArticleIdList><ArticleId IdType="pubmed">23855120</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JF, Yu N, Pan YX, He SJ, Xu LJ, Cao RY, Li YX, Zhu SY, Zhang Y, Qin ED. Phenotypic and genomic characterization of human coxsackievirus A16 strains with distinct virulence in mice. Virus Res. 2014;179:212&#x2013;219. doi: 10.1016/j.virusres.2013.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.10.020</ArticleId><ArticleId IdType="pubmed">24211607</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng S, Wei Y, Zhao SY, Lin XY, Shao QM, Wang J. Intestinal detoxification time of hand-foot-and-mouth disease in children with EV71 infection and the related factors. World J Pediatr. 2015;11:380&#x2013;385. doi: 10.1007/s12519-015-0045-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-015-0045-z</ArticleId><ArticleId IdType="pubmed">26454441</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein MH. EV71 vaccines: A first step towards multivalent hand, foot and mouth disease vaccines. Expert Rev Vaccines. 2015;14:337&#x2013;340. doi: 10.1586/14760584.2015.993385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2015.993385</ArticleId><ArticleId IdType="pubmed">25536888</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>